Ethosuximide plus pentoxifylline for IBS belly pain
Part of Digestive system clinical trials.
This Phase 3 study tests whether two medicines (ethosuximide and pentoxifylline) can reduce belly pain from irritable bowel syndrome (IBS). It may help people whose IBS pain has been moderate to severe recently and who can keep their current IBS treatment steady.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have IBS based on the Rome IV criteria (a specific checklist used to define IBS).
- In the last 7 days, your average belly pain score was 4 or higher out of 10.
- Your IBS treatment has stayed the same for at least 1 month.
- If you can become pregnant: you have a negative pregnancy test and use reliable birth control.
- You are not breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests three treatments for diarrhea-predominant irritable bowel syndrome (IBS-D): brain stimulation (TMS), medication, or probiotics. It aims to find which approach works best to reduce pain and improve bowel symptoms.
This study tests if a drug called psilocybin, given with talk therapy, can help people with severe irritable bowel syndrome (IBS) that hasn't gotten better with standard treatments. If it works, it could offer a new way to manage IBS symptoms.
This Phase 3 study compares ebastine and mebeverine to see which works better for people with IBS that is not constipation-predominant. If you have IBS symptoms without an underlying intestinal disease, you may be offered one of these medicines and monitored for symptom improvement.
This trial tests whether a home device that uses mild skin electrical stimulation can reduce belly pain from IBS with constipation. It also checks whether the treatment is safe and helpful for symptom relief over the study period.
This study tests whether a low-FODMAP diet combined with PEG 3350 can reduce symptoms in adults with IBS-C (irritable bowel syndrome with constipation). It may help improve bowel habits and abdominal pain, and it checks which people can safely follow the diet and treatment plan.
This study tests a new way to measure belly pain in people with IBS using special sensors. It may help doctors better understand and treat your pain.
Hear when a new IBS - Irritable Bowel Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.